Segment Information - Schedule of Unaudited Condensed Consolidated Statements of Operations (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
Sep. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2024 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Schedule of Unaudited Condensed Consolidated Statements of Operations [Line Items] | ||||||||
| Revenues, net | $ 8,666,261 | $ 11,392,078 | $ 45,606,134 | $ 51,984,361 | ||||
| Less cost of goods sold | 10,116,838 | 10,728,765 | 42,095,364 | 48,732,206 | ||||
| Less significant segment expenses: | ||||||||
| Impairments of right-of-use assets | 25,855,427 | 25,855,427 | ||||||
| Research and development expenses-related party | 1,085,588 | 826,532 | 1,585,228 | 1,550,833 | ||||
| Stock-based compensation expenses | 279,218 | 326,588 | 982,337 | 527,542 | ||||
| Other segment items: | ||||||||
| Provision for income taxes | ||||||||
| Segment net loss | (36,269,993) | $ (4,285,914) | $ (2,865,442) | (4,084,511) | $ 1,424,146 | $ (2,266,789) | (43,421,349) | (4,927,154) |
| Other Operating Segment [Member] | ||||||||
| Schedule of Unaudited Condensed Consolidated Statements of Operations [Line Items] | ||||||||
| Revenues, net | 8,666,261 | 11,392,078 | 45,606,134 | 51,984,361 | ||||
| Less cost of goods sold | 10,116,838 | 10,728,765 | 42,095,364 | 48,732,206 | ||||
| Less significant segment expenses: | ||||||||
| Commission expenses | 80,826 | 79,616 | 230,965 | 421,802 | ||||
| Marketing consulting expenses | 195,892 | 426,262 | 582,697 | 1,233,821 | ||||
| Products testing and certification expenses | 110,741 | 211,019 | 349,921 | 465,350 | ||||
| Warranty expenses | 34,704 | 69,208 | 198,995 | 344,937 | ||||
| Marketing and advertising expenses | 262,498 | 164,682 | 630,488 | 334,673 | ||||
| Other selling and marketing expenses | 66,090 | 10,067 | 215,940 | 83,214 | ||||
| Payroll and payroll tax expenses | 888,363 | 888,399 | 2,734,084 | 2,825,028 | ||||
| Professional expenses | 344,167 | 441,663 | 2,066,666 | 1,449,299 | ||||
| Insurance expenses | 161,048 | 111,284 | 499,694 | 448,170 | ||||
| Credit losses | 1,681,606 | 401,988 | 1,765,169 | 464,988 | ||||
| Office expenses | 80,614 | 74,883 | 245,717 | 257,609 | ||||
| Rent expenses | 1,404,674 | 66,850 | 2,860,739 | 192,122 | ||||
| Travel expenses | 32,008 | 44,392 | 78,960 | 172,527 | ||||
| Impairments of right-of-use assets | 25,855,427 | 25,855,427 | ||||||
| Other general and administrative | 71,977 | 32,355 | 140,250 | 117,452 | ||||
| Other research and development expenses | 965,380 | 851,932 | 1,153,296 | 1,432,153 | ||||
| Research and development expenses-related party | 22,792 | 91,168 | ||||||
| Stock-based compensation expenses | 279,218 | 326,588 | 982,337 | 527,542 | ||||
| Other segment items: | ||||||||
| Interest expense | 2,304,183 | 1,553,993 | 6,319,324 | 3,005,186 | ||||
| Other expense (income), net | 2,118 | 21,450 | 257 | |||||
| Change in fair value of earnout liabilities | (1,032,267) | (5,687,989) | ||||||
| Provision for income taxes | ||||||||
| Segment net loss | $ (36,269,993) | $ (4,084,511) | $ (43,421,349) | $ (4,927,154) | ||||
| X | ||||||||||
- Definition It represents the amount of changes in fair value of earnout liabilities. No definition available.
|
| X | ||||||||||
- Definition Insurance expenses. No definition available.
|
| X | ||||||||||
- Definition Office expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No definition available.
|
| X | ||||||||||
- Definition Payroll and payroll tax expenses. No definition available.
|
| X | ||||||||||
- Definition Warranty and testing expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss for asset. Includes, but is not limited to, tangible and intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of general expenses not normally included in Other Operating Costs and Expenses. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of selling and marketing expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense related to other loss. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Expenses incurred for travel and entertainment during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|